ANCHIANO THERAPEUTICS LTD's ticker is ANCN and the CUSIP is 03280X102. A total of 5 filers reported holding ANCHIANO THERAPEUTICS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $217,000 | +75.0% | 158,123 | 0.0% | 0.04% | +15.2% |
| Q1 2020 | $124,000 | -71.7% | 158,123 | -49.5% | 0.03% | -61.6% |
| Q4 2019 | $438,000 | -2.2% | 312,980 | +213.0% | 0.09% | 0.0% |
| Q2 2019 | $448,000 | -34.0% | 100,000 | 0.0% | 0.09% | -35.8% |
| Q1 2019 | $679,000 | – | 100,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD | 402,599 | $972,000 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 369,640 | $850,000 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 128,387 | $295,000 | 0.01% |
| Phoenix Holdings Ltd. | 26,087 | $57,000 | 0.00% |
| Virtu Financial LLC | 13,086 | $30,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| FMR LLC | 21,700 | $50,000 | 0.00% |
| DEUTSCHE BANK AG\ | 319 | $0 | 0.00% |
| MORGAN STANLEY | 10,870 | $25,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 396 | $1,000 | 0.00% |